CJ Bioscience said on Friday that it plans to launch its microbiome analysis platform, EzBiome Bioinformatics App (EzBiome), next year.Since July, the company has been conducting a pilot service of EzBiome by opening some functions to bio-industry officials and university professors. On Wednesday, t
Kakao Healthcare has taken the first step toward building a data-driven leading model for clinical trials.Kakao Healthcare said Thursday that a consortium it formed with Kyung Hee Medical Center has been selected as a research conductor to develop new technologies for smart clinical trials. The cons
Coreline Soft said on Friday that inquiries for its AVIEW Pseudomyzation Sever are increasing in response to the Ministry of Health and Welfare (MOHW) announcement to strengthen medical data security policies.While the digitalization of the medical industry has advanced the quality of medical servic
Philips Korea emphasized its intention to zone in on the rising Generation Z as a key consumer group for their 2030 Philips Personal Health plans to expand its consumer base in the Korean market.Philips Personal Health Korea held a press conference on Wednesday at the Plaza Hotel in Seoul.“Philips a
Roche Diagnostics Korea said on Wednesday that two of its Alzhimer’s disease cerebrospinal fluid (CSF) tests won approval from the Ministry of Food and Drug Safety (MFDS). The two tests were approved by the U.S. FDA in December 2022.The Elecsys β-Amyloid (1-42) CSF II (Abeta42) and Elecsys Phospho-T
Lunit, a Korean medical AI company, said on Wednesday that it signed a commercial contract with Cloud Solutions, a Saudi-based subsidiary of Dr. Sulaiman Al Habib Medical Group (HMG), to supply its AI mammography solution, Lunit INSIGHT MMG.This follows the collaboration with Seha Virtual Hospital,
Korean medical artificial intelligence (AI) imaging companies are being placed on the Korea Exchange (KRX)’s investment caution list one after another as their stock prices continues to surge abnormally this year.Most recently, the KRX placed JLK on the investment caution list last Thursday and Frid
NGeneBio said on Monday that it established a fully owned U.S. subsidiary called NGeneBioAI which will operate as an AI precision diagnosis software company.The subsidiary is expected to serve as a bridgehead for NGeneBio to tap into the U.S. cancer diagnosis market valued at approximately $4.1 bill
Lunit said Friday it has signed a contract with the National Police Hospital (NPH) to supply Lunit Insight CXR, an artificial intelligence image analysis solution for chest X-rays.Lunit Insight CXR is software that utilizes AI-based technology to assist medical professionals by reading 10 chest dise
Boditech Med Inc. said it has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for Swab-N-Go Home Test COVID-19 Ag, an at-home Covid-19 diagnostic kit.The company has tried to get the EUA through Immunostics, its U.S. subsidiary, for the past year. It plans to
Waycen’s artificial intelligence solution to help gastric cancer diagnosis has been designated as an innovative medical device.The Ministry of Food and Drug Safety (MFDS) said Wednesday that it has designated Waycen’s gastric cancer image detection and diagnosis aid software, WAYMED Endo ST CS, as t
Novomics, a cancer diagnostics company, has patented a genetic prognostic technology for rectal cancer in Korea, the company said on Friday. The technology can screen high-risk rectal cancer patients who are more likely to have recurrences based on the molecular subtypes of their cancer.In particula
Korea’s DTx market launched in earnest with the domestic approval of two cognitive-based treatment (CBT) digital therapeutics (DTx) for treating insomnia -- Aimmed’s Somzz and Welt’s Pillowbot in February and April, respectively.According to a report released on Tuesday by the Korea Innovative Medic
CGBio, a Korean regenerative biopharmaceutical company, said Tuesday that Novomax Fusion, aitsnext-generation osteo-active bioglass ceramic cage, has received approval from Japan’s Pharmaceutical and Medical Devices Agency (PMDA).According to CGBio, Novomax Fusion is a synthetic glass-ceramic spacer
Seegene's minority shareholders, angered by the continued fall of the company's stock price, are taking collective action, calling for the resignation of the founder and CEO Chun Jong-yoon.Seegene, the maker of Covid-19 PCR test devices, benefited greatly from the Covid-19 pandemic. While the compan
Theragen Bio and Korea University Ansan Hospital (KUAH) said they would team up to utilize precision genomic data.In a memorandum of understanding (MOU) signed between the two organizations last Thursday, Theragen Bio will leverage its over 10 years of expertise and technology to generate and provid
With the increasing incidence of lung cancer in Korea, special attention is being focused on methods to enable early diagnosis of lung cancer to enable better prognosis for patients.The increase in air pollution, smoking rates, and poor industrial working conditions have been cited as the main cause
Hong Kong-based investment firm Well Alike, one of Lunit's early investors, has sold some of its shares in the market.The medical AI company said the sale was in line with Well Alike's investment strategy, having nothing to do with the company’s internal circumstances.On Tuesday, Well Alike sold 588
Lunit said on Wednesday that it will collaborate with Seha Virtual Hospital (SVH) to supply its AI solutions for chest and mammography to drive healthcare transformation across Saudi Arabia in alignment with the Saudi Vision 2030 strategy project.Lunit has already delivered Lunit INSIGHT CXR, its AI
Qiagen Korea said on Monday that its companion diagnostic (CDx) -- screening PIK3CA gene in patients suitable for prescribing Novartis’ breast cancer treatment Piqray (ingredient: alpelisib) -- started receiving reibmursement from July 1.The insurance coverage will benefit postmenopausal patients wi